Cargando…
Rescuing humanity by antimicrobial peptides against colistin-resistant bacteria
ABSTRACT: It has been about a century since the discovery of the first antibiotic, and during this period, several antibiotics were produced and marketed. The production of high-potency antibiotics against infections led to victories, but these victories were temporary. Overuse and misuse of antibio...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125544/ https://www.ncbi.nlm.nih.gov/pubmed/35604438 http://dx.doi.org/10.1007/s00253-022-11940-z |
_version_ | 1784711959143251968 |
---|---|
author | Moghadam, Majid Taati Mojtahedi, Ali Moghaddam, Mehrdad Moosazadeh Fasihi-Ramandi, Mahdi Mirnejad, Reza |
author_facet | Moghadam, Majid Taati Mojtahedi, Ali Moghaddam, Mehrdad Moosazadeh Fasihi-Ramandi, Mahdi Mirnejad, Reza |
author_sort | Moghadam, Majid Taati |
collection | PubMed |
description | ABSTRACT: It has been about a century since the discovery of the first antibiotic, and during this period, several antibiotics were produced and marketed. The production of high-potency antibiotics against infections led to victories, but these victories were temporary. Overuse and misuse of antibiotics have continued to the point that humanity today is almost helpless in the fight against infection. Researchers have predicted that by the middle of the new century, there will be a dark period after the production of antibiotics that doctors will encounter antibiotic-resistant infections for which there is no cure. Accordingly, researchers are looking for new materials with antimicrobial properties that will strengthen their ammunition to fight antibiotic-resistant infections. One of the most important alternatives to antibiotics introduced in the last three decades is antimicrobial peptides (AMPs), which affect a wide range of microbes. Due to their different antimicrobial properties from antibiotics, AMPs can fight and kill MDR, XDR, and colistin-resistant bacteria through a variety of mechanisms. Therefore, in this study, we intend to use the latest studies to give a complete description of AMPs, the importance of colistin-resistant bacteria, and their resistance mechanisms, and represent impact of AMPs on colistin-resistant bacteria. KEY POINTS: • AMPs as limited options to kill colistin-resistant bacteria. • Challenge of antibiotics resistance, colistin resistance, and mechanisms. • What is AMPs in the war with colistin-resistant bacteria? |
format | Online Article Text |
id | pubmed-9125544 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-91255442022-05-23 Rescuing humanity by antimicrobial peptides against colistin-resistant bacteria Moghadam, Majid Taati Mojtahedi, Ali Moghaddam, Mehrdad Moosazadeh Fasihi-Ramandi, Mahdi Mirnejad, Reza Appl Microbiol Biotechnol Mini-Review ABSTRACT: It has been about a century since the discovery of the first antibiotic, and during this period, several antibiotics were produced and marketed. The production of high-potency antibiotics against infections led to victories, but these victories were temporary. Overuse and misuse of antibiotics have continued to the point that humanity today is almost helpless in the fight against infection. Researchers have predicted that by the middle of the new century, there will be a dark period after the production of antibiotics that doctors will encounter antibiotic-resistant infections for which there is no cure. Accordingly, researchers are looking for new materials with antimicrobial properties that will strengthen their ammunition to fight antibiotic-resistant infections. One of the most important alternatives to antibiotics introduced in the last three decades is antimicrobial peptides (AMPs), which affect a wide range of microbes. Due to their different antimicrobial properties from antibiotics, AMPs can fight and kill MDR, XDR, and colistin-resistant bacteria through a variety of mechanisms. Therefore, in this study, we intend to use the latest studies to give a complete description of AMPs, the importance of colistin-resistant bacteria, and their resistance mechanisms, and represent impact of AMPs on colistin-resistant bacteria. KEY POINTS: • AMPs as limited options to kill colistin-resistant bacteria. • Challenge of antibiotics resistance, colistin resistance, and mechanisms. • What is AMPs in the war with colistin-resistant bacteria? Springer Berlin Heidelberg 2022-05-23 2022 /pmc/articles/PMC9125544/ /pubmed/35604438 http://dx.doi.org/10.1007/s00253-022-11940-z Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Mini-Review Moghadam, Majid Taati Mojtahedi, Ali Moghaddam, Mehrdad Moosazadeh Fasihi-Ramandi, Mahdi Mirnejad, Reza Rescuing humanity by antimicrobial peptides against colistin-resistant bacteria |
title | Rescuing humanity by antimicrobial peptides against colistin-resistant bacteria |
title_full | Rescuing humanity by antimicrobial peptides against colistin-resistant bacteria |
title_fullStr | Rescuing humanity by antimicrobial peptides against colistin-resistant bacteria |
title_full_unstemmed | Rescuing humanity by antimicrobial peptides against colistin-resistant bacteria |
title_short | Rescuing humanity by antimicrobial peptides against colistin-resistant bacteria |
title_sort | rescuing humanity by antimicrobial peptides against colistin-resistant bacteria |
topic | Mini-Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125544/ https://www.ncbi.nlm.nih.gov/pubmed/35604438 http://dx.doi.org/10.1007/s00253-022-11940-z |
work_keys_str_mv | AT moghadammajidtaati rescuinghumanitybyantimicrobialpeptidesagainstcolistinresistantbacteria AT mojtahediali rescuinghumanitybyantimicrobialpeptidesagainstcolistinresistantbacteria AT moghaddammehrdadmoosazadeh rescuinghumanitybyantimicrobialpeptidesagainstcolistinresistantbacteria AT fasihiramandimahdi rescuinghumanitybyantimicrobialpeptidesagainstcolistinresistantbacteria AT mirnejadreza rescuinghumanitybyantimicrobialpeptidesagainstcolistinresistantbacteria |